Rheumatologic immune checkpoint inhibitor-related adverse events
Sign Up to like & getrecommendations! Published in 2023 at "Current Opinion in Rheumatology"
DOI: 10.1097/bor.0000000000000935
Abstract: Purpose of review Immune check point inhibitors (ICIs) are a unique class of cancer treatments that harness the body's innate antitumor response. Although these medications have transformed oncology care, they also lead to generalized immune… read more here.
Keywords: oncology; immune checkpoint; rheumatologic immune; immune related ... See more keywords
AB0212 NON-ADHERENCE IN RHEUMATOLOGIC IMMUNE-MEDIATED DISEASES
Sign Up to like & getrecommendations! Published in 2021 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2021-eular.1304
Abstract: Patient adherence is a key determinant of treatment success in rheumatologic immune-mediated diseases. Available data about adherence to biological treatments and factors associated to non-adherence is limited in Spain. Moreover, no studies compare adherence between… read more here.
Keywords: mediated diseases; rheumatologic immune; dispensing visits; immune mediated ... See more keywords